Mass spectrometry is an analytical technique that determines and identifies quantities of a compound within a sample, and it can also identify traces of components at minute concentrations. It is utilized both quantitatively and qualitatively to detect unknown compounds and calculate isotopic composition of a particular element in a molecule. It can also be used to observe fragments of a compound to determine its structure.

A mass spectrometer provides information about the molecular weight of compound. When combined with combustion analysis, it can also produce relative percentage of oxygen, carbon, and hydrogen present, thus being beneficial to determine molecular formula of an unidentified compound. Moreover, it can detect presence of certain elements based on availability of their isotopes in large quantity. Mass spectrometry and combination of other identification techniques can be applied for detection of an unidentified compound, for example, carbon and proton NMR and IR spectroscopy.


Download Request Sample @www.alliedmarketresearch.com/request-sample/2639

Global mass spectrometry market accounted for $4,598 million in 2016, and is estimated to reach at $7,922 million by 2023, registering a CAGR of 8.0% from 2017 to 2023.

Major Leaders:

• Waters Corporation
• Bruker Corporation
• Thermo Fisher Scientific Inc.
• Perkinelmer Inc.
• Shimadzu Corporation.

The pharmaceutical segment was the highest revenue generator in 2016, and is anticipated to continue this trend in future, owing to high need of accurate analytical techniques. Hybrid mass spectrometry is expected to grow at highest rate in the technology segment due to development in hybrid mass spectrometry sector.

In 2016, North America accounted for highest contribution to the total revenue generated, owing to the high investment in R&D activates and abundance in use of mass spectrometry analytical techniques. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, attributable to growth in disposable income, increase in government initiatives to modernize healthcare infrastructure, and rise in healthcare expenditure.

Key Findings of the Mass Spectrometry Market:

• The hybrid mass spectrometry segment is projected to grow at the highest rate during the analysis period.
• The pharmaceuticals segment was the highest revenue contributor in 2016, and is expected to continue its dominance in future.
• North America dominated the global mass spectrometry market, and is projected to grow at a CAGR of 7.5%.
• China is expected to grow at the highest CAGR of 9.7% in the Asia-Pacific market.
• The food & beverage segment is anticipated to grow at the highest CAGR of 8.5%.

Send Enquiry Us @ www.alliedmarketresearch.com/purchase-enquiry/2639

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business f